Mainstream

Aptose Biosciences Approves 1 For 30 Reverse Share Split To Restore Nasdaq Compliance

Aptose Biosciences approves 1-for-30 reverse share split to restore Nasdaq compliance

Aptose Biosciences approves 1-for-30 reverse share split to restore Nasdaq compliance

Post Contentapto, aps:caRead More

You might also be interested in reading Uniswap V4 Expected To Be Huge, But Is This Requirement A Dealbreaker?.

February 18, 2025
In Mainstream